SunBio,Inc. Company Description

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide.

Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage.

The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee.

Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives.

The company was founded in 1997 and is headquartered in Gunpo-si, South Korea.

SunBio,Inc.

Country	South Korea
Founded	1997
Industry	Biological Products, Except Diagnostic Substances

Contact Details

Address: 95, Sanbon-ro Gunpo-si, 15849 South Korea
Phone	82 3 1423 5467
Website	sunbio.com

Stock Details

Ticker Symbol	067370
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2836